Michele Cilli Selected Research

Michele Cilli Research Topics

Disease

46	Neoplasms (Cancer) 02/2024 - 07/2003
32	Neuroblastoma 01/2023 - 11/2003
6	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2007
4	Melanoma (Melanoma, Malignant) 12/2015 - 04/2009
4	Malignant Mesothelioma 09/2015 - 01/2008
3	Neoplasm Metastasis (Metastasis) 01/2012 - 01/2007
3	Lung Neoplasms (Lung Cancer) 12/2011 - 11/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2009 - 04/2008
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 11/2016
2	Inflammation (Inflammations) 05/2022 - 02/2010
2	Triple Negative Breast Neoplasms 10/2016 - 11/2013
2	Hypoxia (Hypoxemia) 11/2014 - 10/2010
2	Mesothelioma 10/2014 - 01/2008
2	Necrosis 09/2013 - 10/2010
1	Reperfusion Injury 05/2022
1	Body Weight (Weight, Body) 05/2022
1	Ischemia 05/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Endometrial Hyperplasia 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 06/2021 - 09/2002
11	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 10/2006
9	Liposomes (Liposome)IBA 11/2018 - 11/2003
7	LigandsIBA 11/2015 - 10/2006
5	Therapeutic UsesIBA 01/2017 - 07/2007
5	CD13 Antigens (Alanine Aminopeptidase)IBA 08/2015 - 11/2003
4	FibrinIBA 01/2021 - 12/2015
4	GelsIBA 01/2021 - 12/2015
4	CytokinesIBA 01/2017 - 07/2009
4	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 03/2003
4	AntibodiesIBA 10/2015 - 09/2002
4	Bortezomib (Velcade)FDA Link 08/2015 - 08/2006
4	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 01/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 07/2007
3	CurcuminIBA 01/2023 - 01/2007
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 11/2013
3	Interleukin-6 (Interleukin 6)IBA 05/2022 - 12/2005
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2012
3	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 11/2003
3	Anaplastic Lymphoma KinaseIBA 10/2015 - 06/2011
3	FenretinideIBA 09/2013 - 02/2009
3	Small Interfering RNA (siRNA)IBA 01/2012 - 06/2011
3	LuciferasesIBA 10/2010 - 01/2008
3	Interleukin-12 (IL 12)IBA 07/2009 - 07/2003
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2009 - 04/2008
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2023 - 10/2010
2	Hormones (Hormone)IBA 12/2020 - 01/2020
2	Calcium-Sensing ReceptorsIBA 01/2020 - 03/2012
2	ManganeseIBA 01/2020 - 03/2012
2	CyclodextrinsIBA 12/2019 - 06/2019
2	AgarIBA 06/2019 - 07/2009
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 10/2015
2	InterferonsIBA 01/2017 - 05/2013
2	matrigelIBA 10/2016 - 01/2012
2	SuspensionsIBA 11/2015 - 08/2006
2	Estrogen Receptor betaIBA 09/2015 - 10/2014
2	TenascinIBA 11/2014 - 10/2011
2	Pemetrexed (MTA)FDA Link 10/2014 - 01/2008
2	Metformin (Glucophage)FDA LinkGeneric 11/2013 - 02/2013
2	RetinoidsIBA 09/2013 - 02/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011 - 06/2011
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 10/2010 - 11/2003
2	AntigensIBA 07/2010 - 09/2002
2	CaspasesIBA 06/2010 - 08/2006
2	Caspase 9IBA 07/2009 - 06/2009
2	Immunoglobulin G (IgG)IBA 07/2003 - 09/2002
1	Tetrazolium SaltsIBA 01/2023
1	DuocarmycinsIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Drug CombinationsIBA 11/2022
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2022
1	ChemokinesIBA 11/2022
1	Interleukin-23 (Interleukin 23)IBA 10/2022
1	Pioglitazone (Actos)FDA Link 05/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2022
1	Peptide TIBA 06/2021
1	NucleolinIBA 06/2021
1	Tamoxifen FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LeptinIBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 11/2018
1	Coloring Agents (Dyes)IBA 11/2018
1	Neuropilin-1IBA 11/2018
1	ponatinibIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017

Therapy/Procedure

22	Therapeutics 01/2023 - 11/2003
7	Drug Therapy (Chemotherapy) 11/2018 - 11/2003
4	Immunotherapy 11/2022 - 11/2007
2	Intravenous Injections 03/2012 - 04/2009
1	Precision Medicine 02/2024
1	Molecular Targeted Therapy 02/2024
1	Lab-On-A-Chip Devices 11/2022
1	Immunomodulation 11/2022
1	Intravenous Administration 01/2017